In The Lancet Infectious Diseases, Patrick Jault and colleagues1 report the results of the PhagoBurn study investigating the efficacy and tolerability of a cocktail of bacteriophages against Pseudomonas aeruginosa in infected burn wounds.
Original Article: [Comment] Phage therapy 2.0: where do we stand?